Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Aerie Pharmaceuticals, Inc. - Common Stock (NQ: AERI ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Nov 18, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 15.24 (31) Ask (Size) 15.25 (201) Prev. Close 15.25 Today's Range N/A - N/A 52wk Range N/A - N/A Shares Outstanding 47,233,646 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Aerie Pharmaceuticals's Return On Capital Employed Overview November 25, 2022 Via Benzinga Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business November 22, 2022 From Alcon Inc. Investors Via Business Wire Performance More News Read More AiViva Reports That Their Promising New Treatment For Wet AMD Is Soon To Be Ready For Clinical Trials November 14, 2022 Via Benzinga Aerie Pharmaceuticals Reports Third Quarter 2022 Financial Results November 03, 2022 From Aerie Pharmaceuticals, Inc. Via Business Wire AERIE PHARMACEUTICALS - INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aerie Pharmaceuticals, Inc. - AERI October 14, 2022 From Kahn Swick & Foti, LLC Via Business Wire Small-Cap Catalyst Pharma Is Among Market's Best Price Performers October 04, 2022 Via MarketBeat Topics Stocks Exposures US Equities Here Are 10 Biotech Stocks — Including Catalyst And Viridian — That Would Have Netted You $10,000 More This Year September 19, 2022 Via Investor's Business Daily Aerie Pharmaceuticals to Host Key Opinion Leader Event on Dry Eye Disease: Current Landscape, Unmet Needs, and Emerging Treatment Options September 13, 2022 From Aerie Pharmaceuticals, Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For August 29, 2022 August 29, 2022 Via Benzinga AERIE PHARMACEUTICALS - INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aerie Pharmaceuticals, Inc. - AERI August 24, 2022 From Kahn Swick & Foti, LLC Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2022 August 24, 2022 Via Benzinga Aerie Pharmaceuticals's Return On Capital Employed Overview August 24, 2022 Via Benzinga AERI Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Aerie Pharmaceuticals, Inc. Is Fair to Shareholders August 24, 2022 From Halper Sadeh LLP Via Business Wire Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday August 24, 2022 Via Benzinga Macy's, Palo Alto Networks And Other Big Gainers From Tuesday August 24, 2022 Via Benzinga Alcon May Struggle To Meet 2023 Margin Targets With This Latest Acquisition, Says This Analyst August 23, 2022 Via Benzinga Dow Drops Over 100 Points; Aerie Pharmaceuticals Shares Spike Higher August 23, 2022 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session August 23, 2022 Via Benzinga Stocks Cut Lower As Dow Sheds Another Triple Digits August 23, 2022 Via Talk Markets Nasdaq Turns Lower; Crude Oil Rises Sharply August 23, 2022 Via Benzinga Why Windtree Therapeutics Is Trading Higher By Over 60%, Here Are 61 Stocks Moving In Tuesday's Mid-Day Session August 23, 2022 Via Benzinga Why Is Ocugen (OCGN) Stock Climbing Higher Today? August 23, 2022 Via InvestorPlace Aerie Pharmaceuticals (NASDAQ: AERI) Enters into Agreement to be Acquired by Alcon (NYSE: ALC) for $770 Million August 23, 2022 Via Spotlight Growth INTC Stock Alert: What to Know as Intel Co-Invests in Arizona Chip Factories August 23, 2022 Via InvestorPlace Why Is Aerie Pharmaceuticals (AERI) Stock Up 35% Today? August 23, 2022 Via InvestorPlace Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
